Depressive disorder, major Trials in Philadelphia, United States
Conditions / Depressive disorder, major / Philadelphia, United States
Clinical trials for Depressive disorder, major investigate a range of treatment strategies and patient populations.
29 total trials for this combination
Showing top 10 of 29 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05518149 | A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) | TERMINATED | — |
| NCT06559306 | Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms | RECRUITING | PHASE3 |
| NCT01360645 | Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial) | COMPLETED | PHASE3 |
| NCT00369343 | Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) Versus Placebo in Peri- and Postmenopausal Women | COMPLETED | PHASE3 |
| NCT01360632 | Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial) | COMPLETED | PHASE3 |
| NCT01360866 | Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial) | COMPLETED | PHASE3 |
| NCT03288714 | Adaptive Design Study of NEST sTMS in Subjects With Major Depressive Disorder | COMPLETED | NA |
| NCT00406640 | Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal Women | COMPLETED | PHASE3 |
| NCT02196506 | Study of the Safety and Efficacy of Fixed-dose Brexpiprazole (OPC-34712) as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder With and Without Anxious Distress | COMPLETED | PHASE3 |
| NCT07412756 | A Study of Brenipatide in Adult Participants With Major Depressive Disorder | NOT_YET_RECRUITING | PHASE3 |